- Home
- DT vs RGC Comparison
DT vs RGC Comparison
Compare DT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DT | RGC |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.5B |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DT | RGC |
|---|---|---|
| Price | $32.19 | $29.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 24 | 0 |
| Target Price | ★ $52.83 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 174.8K |
| Earning Date | 05-13-2026 | 10-31-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 205.77 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $1,698,683,000.00 | N/A |
| Revenue This Year | $21.74 | N/A |
| Revenue Next Year | $14.85 | N/A |
| P/E Ratio | $70.43 | ★ N/A |
| Revenue Growth | ★ 18.75 | N/A |
| 52 Week Low | $33.24 | $9.39 |
| 52 Week High | $57.55 | $950.00 |
Technical Indicators
Market Signals| Indicator | DT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 30.26 | 54.24 |
| Support Level | N/A | $22.43 |
| Resistance Level | $39.66 | $37.83 |
| Average True Range (ATR) | 1.50 | 3.55 |
| MACD | -0.47 | 0.36 |
| Stochastic Oscillator | 7.97 | 35.65 |
Price Performance
Historical ComparisonAbout DT Dynatrace Inc.
Dynatrace is a software-as-a-service company that enables customers to monitor and analyze their information technology infrastructure, from servers to applications and Python scripts. Dynatrace's unified platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to optimize their business for service-level objectives and ensure uptime.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.